Get the Stockscreener App
5.97
2.13%
-0.13
After Hours:
5.89
-0.08
-1.34%
Nanovibronix Inc stock is traded at $5.97, with a volume of 48,684.
It is down -2.13% in the last 24 hours and up +35.99% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
See More
Previous Close:
$6.10
Open:
$6.05
24h Volume:
48,684
Relative Volume:
0.03
Market Cap:
$5.77M
Revenue:
$3.29M
Net Income/Loss:
$-3.09M
P/E Ratio:
-4.8537
EPS:
-1.23
Net Cash Flow:
$-2.46M
1W Performance:
-21.45%
1M Performance:
+35.99%
6M Performance:
-1.14%
1Y Performance:
-27.16%
1-Day Range:
$5.8601
$6.22
1-Week Range:
$5.8601
$7.5475
52-Week Range:
$1.92
$16.10
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
5.97 | 5.77M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Nanovibronix Inc Stock (NAOV) Latest News
NanoVibronix regains Nasdaq compliance - Medical Buyer
NanoVibronix (NAOV) Secures Nasdaq Listing Compliance | NAOV Sto - GuruFocus
NanoVibronix Regains Nasdaq Compliance | NAOV Stock News - GuruFocus
NanoVibronix regains compliance with Nasdaq listing rules By Investing.com - Investing.com South Africa
NAOV Stock Alert: What’s Driving the Surge? - timothysykes.com
NanoVibronix secures $360K note, meets Nasdaq compliance By Investing.com - Investing.com South Africa
Nanovibronix Regains Nasdaq Compliance - marketscreener.com
NanoVibronix secures $360K note, meets Nasdaq compliance - Investing.com
NanoVibronix regains compliance with Nasdaq listing rules - Investing.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Medical Tech Firm NanoVibronix Beats Delisting Threat: What's Next for Investors? - Stock Titan
Surge In NanoVibronix (NAOV) Shares Sparks Market Curiosity - Stocks Telegraph
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
NanoVibronix stock hits 52-week high of $14.1 amid growth By Investing.com - Investing.com Australia
Nanovibronix (NAOV) Surges 36.5% Amid UroShield Device Success - GuruFocus
UroShield by NanoVibronix (NAOV) Shown to Reduce Healthcare Costs and Improve Patient Care - GuruFocus
NanoVibronix (NAOV) Announces Reverse Stock Split - GuruFocus
NanoVibronix (NAOV) Completes Acquisition of ENvue Medical Holdi - GuruFocus
NanoVibronix (NAOV) Expands UroShield Distribution Across Austra - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
NanoVibronix stock hits 52-week high of $14.1 amid growth - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
NanoVibronix Stock Skyrockets: What’s Behind This Surge? - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
NanoVibronix Announces Reimbursement Approvals for PainShield(R) in the U.S. - ACCESS Newswire
NanoVibronix announces board member resignation - Investing.com India
NanoVibronix announces board member resignation By Investing.com - Investing.com UK
NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia - BioSpace
NanoVibronix expands distribution in Australia after study By Investing.com - Investing.com India
NanoVibronix expands distribution in Australia after study - Investing.com Australia
NanoVibronix Inc. (NAOV) reports earnings - Quartz
NanoVibronix, Inc. SEC 10-K Report - TradingView
Why Nanovibronix Inc. (NAOV) Surged On Thursday? - MSN
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
NanoVibronix Inc (NASDAQ: NAOV) Gains 55.49% In Early Trade; What Lies Ahead? - stocksregister.com
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 - MSN
NanoVibronix (NAOV) Stock Is Skyrocketing: What's Going On? - Benzinga India
NanoVibronix (NAOV) Stock Surges In Pre-Market Trading Following A Positive Study - Stocks Telegraph
Top Premarket Gainers -March 17, 2025 at 07:39 am EDT - Marketscreener.com
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India
NanoVibronix announces UroShield health service study data published - TipRanks
NanoVibronix’s UroShield Study Published in Medical Journal - TipRanks
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):